Вы искали: genotypic (Английский - Мальтийский)

genotypic characteristic
karatteristika ġenotipika

genotypic resistance:
reżistenza ġenotipika:

genotypic ss in obt
ġenotipika f’ obt

- emerging genotypic etvr
c - etvr ġenotipika ġdida

genotypic resistance testing
ittestjar għal reżistenza ġenotipika

c - emerging genotypic etvr
c - etvr ġenotipika ġdida

baseline genotypic sensitivity scorea
punteġġ ta’ sensittività ġenotipika fil-linja bażia

analyses based on genotypic resistance testing.
analiżi bbażata fuq testijiet ta’ reżistenza ġenotipika

genotypic mutation pattern and cross-resistance
it-tip ta’ mutazzjoni ġenotipika u cross-resistance

antiviral activity according to genotypic/phenotypic resistance
attività antivirali skont ir-reżistenza ġenotipika/fenotipika

other phenotypic and genotypic assays are currently being evaluated.
analiżi oħrajn tat-tip fenotipiċi u ġenotipiċi qed jiġu attwalment evalwati.

genotypic sensitivity scores were not obtained for all patients at baseline.
punteġġi ta’ sensittività ġenotipika ma nkisbux għal pazjenti kollha fil-linja bażi.

genotypic entecavir resistance through year 5, lamivudine-refractory studies
reżistenza Ġenotipika għal entecavir sa sena 5, studji dwar pazjenti refrattarji għal lamivudine

emerging genotypic entecavir resistance through year 5, nucleoside-naive studies
reżistenza Ġenotipika Ġdida għal entecavir sa sena 5, studji dwar pazjenti li qatt ma Ħadu nukleoside

emerging genotypic entecavir resistance through year 5, nucleoside-naive studies a
11 reżistenza Ġenotipika Ġdida għal entecavir sa sena 5, studji dwar pazjenti li qatt ma Ħadu nukleoside a

genotypic analysis was conducted for 5 subjects in the tenofovir disoproxil fumarate arm post week 48.
saret analiżi ġenotipika għal 5 individwi fil-fergħa ta’ tenofovir disoproxil fumarate wara ġimgħa 48.

the clinical relevance of phenotypic and genotypic changes associated with viramune therapy has not been established.
42 l- implikazzjoni klinika ta 'bidliet fenotipiċi u ġenotipiċi li huma assoċjati ma ’ terapija b’ viramune ma ġietx stabbilita.

genotypic correlates of reduced phenotypic susceptibility to lopinavir in viruses selected by other protease inhibitors.
korrelati ġenotipiċi ta’ suxxettibilità fenotipika mnaqqsa għal lopinavir fil-virus selezzjonati minn inibituri oħra tal-protease.

through 48 weeks of treatment, two types of analyses were performed based on baseline genotypic mutations.
matul 48 ġimgħa ta 'kura, saru żewġ tipi ta' analiżi bbażati fuq linja bażi ta 'mutazzjonijiet ġenotipiċi.

higher response rates were observed in patients with genotypic sensitivity score (gss) > 0.
kienu osservati rati ta ’ rispons ogħla f’ pazjenti b’ punteġġ ta ’ sensittività Ġenotipika (gss) > 0.